- Archives
-
-
-
-
-
-
-
-
-
-
An interview with Dr. Frank Walsh, Head of Discovery Research, on Wyeth's outsourcing strategy
Gil Roth
Mitigating risks & ensuring compliance
Jeff Clark
Is a new FDA guidance imminent?
Tom Spurgeon
Gil Roth
With productivity and efficiencies on the climb, the outlook for contract services is most definitely rosy
Joanna Cosgrove
Insulin facility cancelled, bio-plans unveiled
Joanna Cosgrove
Formulation development opportunities abound
Neil Canavan
Don’t outsource a process you don’t understand
Ronald D. Snee
Two design experts share their tips for bringing labs into the 21st Century
David Callan and Markus Yakren
Andy Signore discusses health, safety & environmental issues in facility design
Tom Spurgeon
Best practices for the worst situations
Hemant Vora
How will they affect CTM providers?
Kristin Brooks
Key elements of the laboratory auditing process
Philippe Ourisson
Guidelines for early-stage research issues
Jeffrey M. Marra
Is it headed towards remission or a relapse?
Dr. Enrico T. Polastro and Sonia Tulcinsky
Gil Y. Roth
Successful deployment of Lean at Amgen
Chris Driscoll
Understanding their functions benefits process control
Lokesh Bhattacharyya, Ph.D.
Current issues in safety evaluation
Steve Barkyoumb, DVM, Ph.D.; Chris Springall, M.D.; Friedhelm Vogel, Ph.D., Richard Crowley
Will 45% excess capacity drive the industry?
Eliza Yibing Zhou
Growth, Expansion and New Opportunities
Kristin Brooks
Combating the staffing shortage in drug safety monitoring through creative staffing plans
Kelli Henry
Next-generation outsourcing strategies
Monique Garrett
Our annual look at outsourcing trends and attitudes
A sector driven by solid, veteran performers braces for growth — but how much and from where?
Tom Spurgeon
Using a risk-based approach from discovery to proof of concept
James Murtagh
Are attitudes changing?
Sandra Fox
It’s all about location - but what makes a location good?
Gil Y. Roth
Opportunities abound for solid dose CMOs
Gil Y. Roth
A guide to selecting a trusted biorepository partner
F. John Mills, M.D., Ph.D.
How Pharma can improve the value of its growing investment in IT
Marc Swenson
Our financial analyst sums up 2005's big moves
Michael Martorelli
Does it really have to be this difficult?
Monique Garrett
Reward, Risk and Regulation
Kristin Brooks
|
